---
figid: PMC3425519__onc0091211290002
figlink: /pmc/articles/PMC3425519/figure/F2/
number: Figure 2
caption: 'Intracellular vascular endothelial growth factor (VEGF) signal transduction
  pathway. Ligands bind to membrane receptors, which are phosphorylated, leading to
  activation of several cytoplasmic messengers, which activate transcription factors
  in the nucleus that involves target genes implicated in the proliferation, angiogenesis,
  apoptosis, and tumor invasion. Shown are some targeted therapies and their main
  inhibition targets [–]. aVEGF A–D ligands bind to VEGF receptors 1–3 with specific
  ligands preferentially binding to a specific receptor (e.g., VEGF A and C ligands
  bind to VEGF receptor 2); bmAb to VEGF A; ctargets VEGF A and B and placental growth
  factor (PlGF); dmAb to VEGF receptor 1; emAb to VEGF receptor 2.Abbreviations: AKT,
  protein kinase B; BCR-ABL, Philadelphia chromosome; BRaf, B-type RAF kinase; C-src,
  cellular sarcoma; Grb, growth factor receptor–bound protein; JAK/STAT, Janus kinases/signal
  transducers and activators of transcription; MAPK, mitogen-activated protein kinase;
  MEK, MAPK kinase; mTOR, mammalian target of rapamycin; PI(4,5)P2, phosphatidylinositol
  (3,4) biphosphate; PI(3,4,5)P3, phosphatidylinositol (3,4,5) triphosphate; PI3K,
  phosphatidylinositol 3-kinase; PTC, papillary thyroid cancer; PTEN, phosphatase
  and tensin homologue; RET, rearranged during transfection; Shc, Src homology 2 domain-containing
  transforming protein; Sos, son of sevenless protein. Adapted from []. Copyright
  2010 Springer. Reprinted with kind permission from Springer Science+Business Media
  B.V.'
pmcid: PMC3425519
papertitle: Targeting Angiogenesis in Metastatic Breast Cancer.
reftext: Sangeetha Reddy, et al. Oncologist. 2012 Aug;17(8):1014-1026.
pmc_ranked_result_index: '196916'
pathway_score: 0.9497943
filename: onc0091211290002.jpg
figtitle: Intracellular vascular endothelial growth factor (VEGF) signal transduction
  pathway
year: '2012'
organisms: Homo sapiens
ndex: fc8bb868-deea-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3425519__onc0091211290002.html
  '@type': Dataset
  description: 'Intracellular vascular endothelial growth factor (VEGF) signal transduction
    pathway. Ligands bind to membrane receptors, which are phosphorylated, leading
    to activation of several cytoplasmic messengers, which activate transcription
    factors in the nucleus that involves target genes implicated in the proliferation,
    angiogenesis, apoptosis, and tumor invasion. Shown are some targeted therapies
    and their main inhibition targets [–]. aVEGF A–D ligands bind to VEGF receptors
    1–3 with specific ligands preferentially binding to a specific receptor (e.g.,
    VEGF A and C ligands bind to VEGF receptor 2); bmAb to VEGF A; ctargets VEGF A
    and B and placental growth factor (PlGF); dmAb to VEGF receptor 1; emAb to VEGF
    receptor 2.Abbreviations: AKT, protein kinase B; BCR-ABL, Philadelphia chromosome;
    BRaf, B-type RAF kinase; C-src, cellular sarcoma; Grb, growth factor receptor–bound
    protein; JAK/STAT, Janus kinases/signal transducers and activators of transcription;
    MAPK, mitogen-activated protein kinase; MEK, MAPK kinase; mTOR, mammalian target
    of rapamycin; PI(4,5)P2, phosphatidylinositol (3,4) biphosphate; PI(3,4,5)P3,
    phosphatidylinositol (3,4,5) triphosphate; PI3K, phosphatidylinositol 3-kinase;
    PTC, papillary thyroid cancer; PTEN, phosphatase and tensin homologue; RET, rearranged
    during transfection; Shc, Src homology 2 domain-containing transforming protein;
    Sos, son of sevenless protein. Adapted from []. Copyright 2010 Springer. Reprinted
    with kind permission from Springer Science+Business Media B.V.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SHC1
  - JAK3
  - SHC3
  - RET
  - JAK2
  - TYK2
  - AKT3
  - TAS2R38
  - HRAS
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK9
  - MAPK1
  - VEGFB
  - MTOR
  - BRAF
  - AKT1
  - SHC4
  - VEGFC
  - JAK1
  - NRAS
  - PGF
  - MAP2K2
  - AKT2
  - MAP2K1
  - MAPK10
  - MAPK3
  - PTEN
  - KRAS
  - SHC2
  - SOS2
  - STAT1
  - VEGFA
  - MAPK14
  - MAPK12
  - SRC
  - STAT2
  - SOS1
  - VEGFD
  - GRB2
  - STAT5B
  - STAT3
  - STAT5A
  - STAT6
  - STAT4
  - Temsirolimus
  - Vatalanib
  - Vandetanib
  - Dovitinib
  - Cediranib
  - Pazopanib
  - Foretinib
  - Cabozantinib
  - Cancer
  - Lung cancer
  - Noonan syndrome
genes:
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: RET/PTC
  symbol: RET
  source: hgnc_symbol
  hgnc_symbol: RET
  entrez: '5979'
- word: JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: RET/PTC
  symbol: PTC
  source: hgnc_prev_symbol
  hgnc_symbol: TAS2R38
  entrez: '5726'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: BRaf
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: C-src
  symbol: c-src
  source: hgnc_alias_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Grb2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
chemicals:
- word: Temsirolimus
  source: MESH
  identifier: C401859
- word: Vatalanib
  source: MESH
  identifier: C404768
- word: Vandetanib
  source: MESH
  identifier: C452423
- word: Dovitinib
  source: MESH
  identifier: C500007
- word: Cediranib
  source: MESH
  identifier: C500926
- word: Pazopanib
  source: MESH
  identifier: C516667
- word: Foretinib
  source: MESH
  identifier: C544831
- word: Cabozantinib
  source: MESH
  identifier: C558660
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
